US approves highly anticipated Eli Lilly weight loss drug

by

The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly’s highly anticipated weight loss drug Zepbound.

Leave A Comment

Your email address will not be published. Required fields are marked *